Clinical Laboratories | Tissuepathology.com

ASCO: Now and Then

Dr. Keith J. Kaplan — Thu, 11 Jun 2026 18:00:28 +0000

In medical school I drove a cab at night to make ends meet. I rented the medallion from a guy for $50 and kept the difference I made. The Army paid me $692 a month stipend on the Health Professions Scholarship and the studio apartment in downtown Chicago was $1000/month. I wasshort over $300 a […]

The post ASCO: Now and Then first appeared on Tissuepathology.com.

Mayo Clinic Digital Pathology building ecosystem to advance next-generation diagnostics

Erica Goodpaster — Mon, 25 May 2026 12:34:47 +0000

ROCHESTER, Minn. — Mayo Clinic Digital Pathology (MCDP) is advancing efforts to build an integrated innovation ecosystem that supports the future of pathology across clinical care and research. The work reflects Mayo Clinic’s broader digital pathology strategy, including investments in emerging companies, expanded use of digitized pathology data and collaborations designed to improve diagnostic workflows and speed. […]

The post Mayo Clinic Digital Pathology building ecosystem to advance next-generation diagnostics first appeared on Tissuepathology.com.

Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use

Erica Goodpaster — Fri, 22 May 2026 13:53:07 +0000

CHICAGO–(BUSINESS WIRE)–Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced the clinical launch of the ArteraAI Prostate Test (mHSPC). The CLIA-certified and CAP-accredited prognostic test will be fully integrated into the Tempus platform, providing urologists and oncologists with a digital pathology solution that helps inform personalization of therapy intensity in patients […]

The post Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use first appeared on Tissuepathology.com.

What’s New in Glencoe Software’s PathViewer 3.16.1

Erica Goodpaster — Thu, 30 Apr 2026 13:30:19 +0000

From the Glencoe Software blog We are excited to announce the release of PathViewer 3.16.1! This version introduces enhanced mask support, improved channel controls, and expanded dataset-level annotation customization. Auto-Min/Max Channel Control An auto-min/max button has been added to the Viewing Options channel controls, allowing all visible channels to be scaled to their histogram range […]

The post What’s New in Glencoe Software’s PathViewer 3.16.1 first appeared on Tissuepathology.com.

Fimlab expands utilization of Aiforia’s clinical AI solutions

Erica Goodpaster — Mon, 27 Apr 2026 12:10:53 +0000

Fimlab Laboratories expands the use of Aiforia’s AI solutions for breast cancer diagnostics, bringing multi-organ Ki67 biomarker quantification into routine clinical use. Aiforia Technologies Plc, Press Release, April 27, 2026 at 9:00 a.m. EEST Aiforia Technologies Plc announced today that Fimlab Laboratories in Finland has expanded the use of Aiforia’s AI solutions in routine clinical […]

The post Fimlab expands utilization of Aiforia’s clinical AI solutions first appeared on Tissuepathology.com.

Panakeia Unveils Landmark Metabolic and Pathway Activation Data in Cancers at AACR 2026

Erica Goodpaster — Fri, 24 Apr 2026 12:37:33 +0000

CAMBRIDGE, UK — April 21, 2026 — Panakeia (“the Company”), the world’s first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for Cancer Research (AACR) Annual Meeting 2026, further proving its unique capability to unlock complete biological blueprints essential for drug discovery and clinical decision-making. The Company revealed […]

The post Panakeia Unveils Landmark Metabolic and Pathway Activation Data in Cancers at AACR 2026 first appeared on Tissuepathology.com.